Characterization of the dopamine receptor system in adult rhesus monkeys exposed to cocaine throughout gestation

Psychopharmacology

Volumn 210, Issue 4, 2010, Pages 481-488

  Hamilton, Lindsey R ^a   Czoty, Paul W ^a   Gage, H Donald ^a   Nader, Michael A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

D2 receptors; Pet imaging; Prenatal cocaine; Quinpirole; Rhesus monkey; SKF81297

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; FLUOROCLEBOPRIDE F 18; QUINPIROLE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; DRUG UPTAKE; EYELID REFLEX; FEMALE; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PUTAMEN; RHESUS MONKEY; SEX DIFFERENCE; YAWNING;

ANIMALS; BENZAMIDES; BENZAZEPINES; BLINKING; COCAINE; DOPAMINE AGONISTS; FEMALE; FLUORINE RADIOISOTOPES; MACACA MULATTA; MALE; PIPERIDINES; PREGNANCY; PREGNANCY, ANIMAL; PRENATAL EXPOSURE DELAYED EFFECTS; QUINPIROLE; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; YAWNING;

EID: 77955662123     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1847-2     Document Type: Article

References (52)

1. Bayer LE, Brown A, Mactutus CF, Booze RM, Strupp BJ (2000) Prenatal cocaine exposure increases sensitivity to the attentional effects of the dopamine D1 agonist SKF81297. J Neurosci 20:8902-8908
2. Bettinardi V, Pagani E, Gilardi MC et al (1999) An automatic classification technique for attenuation correction in positron emission tomography. Eur J Nucl Med 26:447-458
3. Bhide PG (2009) Dopamine, cocaine, and the development of cerebral cortical cytoarchitecture: a review of current concepts. Semin Cell Dev Biol 20:395-402
4. Boulay D, Depoortere R, Perrault G, Borrelli E, Sanger DJ (1999a) Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. N. Neuropharmacology 38:1389-1396
5. Boulay D, Depoortere R, Rostene W, Perrault G, Sanger DJ (1999b) Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice. N. Neuropharmacology 38:555-565
6. Chaperon F, Tricklebank MD, Unger L, Neijt HC (2003) Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors. Neuropharmacology 44:1047-1053
7. Christian BT, Vandehey NT, Fox AS et al (2009) The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging. Neuroimage 44:1334-1344
8. Code RA, Tang AH (1991) Yawning produced by dopamine agonists in rhesus monkeys. Eur J Pharmacol 201:235-238
9. Collins GT, Witkin JM, Newman AH et al (2005) Dopamine agonistinduced yawning in rats: a dopamine D3 receptor-mediated behavior. J Pharmacol Exp Ther 314:310-319
10. Collins GT, Newman AH, Grundt P et al (2007) Yawning and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists. Psychopharmacology 193:159-170
11. Czoty PW, Morgan D, Shannon EA, Gage HD, Nader MA (2004) Characterization of dopamine D1 receptor function in socially housed cynomolgus monkeys. Psychopharmacology 174:381-388
12. Czoty PW, McCabe C, Nader MA (2005) Assessment of the reinforcing strength of cocaine in socially housed monkeys using a choice procedure. J Pharmacol Exp Ther 312:96-102
13. Czoty PW, Riddick NV, Gage HD (2009) Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys. Neuropsychopharmacology 34:548-554
14. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62:1377-1381
15. Fang Y, Janowsky A, Ronnekleiv OK (1997) Cocaine exposure in fetal rhesus monkey: consequences for dopamine D1-and D2-like receptor binding densities. Brain Res Dev Brain Res 104:163-174
16. Farde L, Hall H, Pauli S, Halldin C (1995) Variability in D2-dopamine receptor density and affinity: a PET study with [11C]reclopride in man. Synapse 20:200-208
17. Friedman E, Yadin E, Wang HY (1996) Effects of prenatal cocaine on dopamine receptor-G protein coupling in mesocortical regions of the rabbit brain. Neuroscience 70:739-747
18. Jones LB, Stanwood GD, Reinoso BS et al (2000) In utero cocaineinduced dysfunction of dopamine D1 receptor signaling and abnormal differentiation of cerebral cortical neurons. J Neurosci 20:4606-4614
19. Jutkiewicz EM, Bergman J (2004) Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions. J Pharmacol Exp Ther 1999:649-661
20. Laakso A, Vilkman H, Bergman J et al (2002) Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Soc Biol Psychiatry 52:759-763
21. Lidow MS (1998) Nonhuman primate model of the effect of prenatal cocaine exposure on cerebral cortical development. Ann NY Acad Sci 846:182-193
22. Logan J, Fowler JS, Volkow ND et al (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834-840
23. Mach RH, Luedtke RR, Unsworth CD et al (1993) 18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography. J Med Chem 36:3707-3720
24. Mach RH, Nader MA, Ehrenkaufer RL et al (1996) Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography. Synapse 24:322-333
25. Martelle JL, Claytor R, Ross JT et al (2007) Effects of two novel D3-selective compounds, NGB 2904 and CJB 090, on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 321:573-582
26. Martinez D, Broft A, Foltin RW et al (2004) Cocaine dependence and D2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 29:1190-1202
27. Moody CA, Frambes NA, Spear LP (1992) Psychopharmacological responsiveness to the dopamine agonist quinpirole in normal weanlings and in weanling offspring exposed gestationally to cocaine. Psychopharmacology 108:256-262
28. Moore RJ, Vinsant SL, Nader MA, Porrino LJ, Friedman DP (1998a) Effect of cocaine self-administration on striatal dopamine D1 receptors in rhesus monkeys. Synapse 28:1-9
29. Moore RJ, Vinsant SL, Nader MA et al (1998b) Effect of cocaine selfadministration on dopamine D2 receptors in rhesus monkeys. Synapse 30:88-96
30. Morgan D, Grant KA, Gage HD et al (2002) Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 5:169-174
31. Morris P, Binienda Z, Gillam MP et al (1996) The effect of chronic cocaine exposure during pregnancy on maternal and infant outcomes in the rhesus monkey. Neurotoxicol Teratol 18:147-154 (Pubitemid 26115051)
32. Morris P, Binienda Z, Gillam MP et al (1997) The effect of chronic cocaine exposure throughout pregnancy on maternal and infant outcomes in the rhesus monkey. Neurotoxicol Teratol 19:47-57
33. Munro CA, McCaul ME, Wong DF et al (2006) Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59:966-974
34. Nader MA, Grant KA, Gage HD et al (1999) PET imaging of dopamine D2 receptors with [18F]fluoroclebopride in monkeys: effects of isoflurane-and ketamine-induced anesthesia. Neuropsychopharmacology 21:35-46
35. Nader MA, Daunais JB, Moore T et al (2002) Effects of cocaine selfadministration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology 21:589-596
36. Nader MA, Morgan D, Gage HD et al (2006) PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 9:1050-1056
37. Nader MA, Czoty PW, Gould RW, Riddick NV (2008) PET imaging studies of dopamine receptors in primate models of addiction. Phil Trans Royal Soc B 363:3223-3232
38. Nair BS, Watson RR (1991) Cocaine and the pregnant woman. J Reprod Med 36:862-867
39. Paule MG, Gillam MP, Binienda Z, Morris P (1996) Chronic cocaine exposure throughout gestation in the rhesus monkey. Pregnancy outcomes and offspring behavior. Ann NY Acad Sci 801:301-309 (Pubitemid 27029017)
40. Paule MG, Gillam MP, Allen RR, Chelonis JJ (2000) Effects of chronic in utero exposure to cocaine on behavioral adaptability in rhesus monkey offspring when examined in adulthood. Ann NY Acad Sci 914:412-417
41. Pohjalainen T, Rinne JO, Nagren K et al (1998) Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am J Psychiatry 155:768-773
42. Rogers JG, Harrop R, Kinahan PE (1987) The theory of threedimensional image reconstruction for PET. IEEE Trans Med Imaging 6:239-243
43. Silk J, Short J, Roberts J, Kusnitz J (1993) Gestation length in rhesus macaques (Macaca mulatta). Intern J Primatol 14:95-104
44. Smith S (2002) Fast robust automated brain extraction. Hum Brain Map 17:143-155
45. Sokoloff P, Diaz J, Le Foll B, Guillin O, Leriche L, Bezard E, Gross C (2006) The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol Disord Drug Targets 5:25-43
46. Staley JK, Mash DC (1996) Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 16:6100-6106
47. Stanwood GD, Levitt P (2007) Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution. J Neurosci 27:152-157
48. United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration SAMHSA Office of Applied Studies (1996) Results from the 1992 National Pregnancy and Health Survey. A report
49. Unterwald EM, Ivkovic CM et al (2003) Prenatal exposure to cocaine decreases adenylyl cyclase activity in embryonic mouse striatum. Brain Res Dev Brain Res 147:67-75
50. Volkow D, Wang GJ, Fowler JS et al (1999) Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D (2) receptors. J Pharmacol Exp Ther 291:409-415
51. Wang HY, Runyan S, Yadin E, Friedman E (1995) Prenatal exposure to cocaine selectively reduces D1 dopamine receptor-mediated activation of striatal Gs proteins. J Pharmacol Exp Ther 273:492-498
52. Woods RP, Mazziotta JC, Cherry SR (1993) MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17:536-546